Proteomic Analysis Revealed Underlying Biological  Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose  Flavonoid Mixture

Tüzüner, Mete; Ceviz, Ayşe

doi:https://dx.doi.org/10.26650/EurJBiol.2021.1017807

Research Article

DOI :10.26650/EurJBiol.2021.1017807 IUP :10.26650/EurJBiol.2021.1017807 Full Text (PDF)

Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture

Objective: A considerable level of evidence has accumulated about the breast cancer risk-reducing effect of consuming specific flavonoids, through the increasing amount of research and epidemiologic studies. Different flavonoids may have different cellular bioavailability and favor, i.e., the occurrence of a hormetic effect, thus it is important to evaluate breast cancer cells’ response to different doses of flavonoids. This study aims to investigate the alterations of the biological pathways in a hormone-positive (HR+) breast cancer cell line as a resemblance for the most common breast cancer subtype, related to the low-dose exposure of the flavonoids. Materials and Methods: Different levels of doses were applied to MCF-7 breast cancer cells. In order to determine cellular proliferation, WST-1 analysis was conducted. The highest proliferation was observed with cell lines exposed to a low-dose flavonoid mixture and these were selected for further analysis. Intracellular protein expression were investigated by peptide analysis on a nano LC-MS/MS platform. A protein-protein interaction network and pathway analysis were conducted for the proteins expressed differently between the groups. Results: A total of 214 proteins were identified and 36 proteins with significant alterations (≥1.2-fold change, p≤0.05) were detected. Significant changes were observed in the pathways related to carbon metabolism, amino acid biosynthesis, splicing mechanism, mitochondrial protein import and translation elongation pathways. Conclusion: Our study demonstrated that flavonoids can have a hormetic effect which can initially alter metabolic pathways vital for cell proliferation and survival. These pathways may include potential targets for enhancing the anticancer activity of the flavonoids.

Keywords: Flavonoids, breast cancer, hormesis, proteomics

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of inci-dence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49. google scholar
2. Rodnguez-Garaa C, Sanchez-Quesada C, J Gaforio J. Dietary Flavonoids as Cancer Chemopreventive Agents: An Updated Review of Human Studies. Antioxidants 2019; 8(5): 137. google scholar
3. Toreti VC, Sato HH, Pastore GM, Park YK, Recent progress of prop-olis for its biological and chemical compositions and its botanical origin, Evid Based Complement Alternat Med 2013; 697390. google scholar
4. Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacolog-ical research of propolis. Phytother Res 2001; 15(7): 561-71. google scholar
5. Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE. Phy-toestrogens and breast cancer risk: Review of the epidemiological evidence. Breast Cancer Res Treat 2003; 77: 171-83. google scholar
6. Lim DW, Giannakeas V, Narod SA. Survival Differences in Chinese Versus White Women With Breast Cancer in the United States: A SEER-Based Analysis. JCO Glob Oncol 2020; 6: 1582-92. google scholar
7. Rupasinghe HP, Ronalds CM, Rathgeber B, Robinson RA. Absorp-tion and tissue distribution of dietary quercetin and quercetin glycosides of apple skin in broiler chickens. J Sci Food Agric 2010; 90(7): 1172-8. google scholar
8. Gonzales GB, Smagghe G, Grootaert C, Zotti M, Raes K, Van Camp J. Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure-activity/property relation-ship-based approach in the study of bioavailability and bioactivity. Drug Metab Rev 2015; 47(2): 175-90. google scholar
9. Seyhan MF, Yılmaz E, Timirci-Kahraman Ö, Saygılı N, Kısakesen Hİ, Gazioğlu S, et al. Different propolis samples, phenolic content, and breast cancer cell lines: Variable cytotoxicity ranging from ineffec-tive to potent. IUBMB Life 2019; 71(5): 619-31. google scholar
10. Bonofiglio D, Giordano C, De Amicis F, Lanzino M, Ando S. Natural Products as Promising Antitumoral Agents in Breast Cancer: Mech-anisms of Action and Molecular Targets. Mini Rev Med Chem 2016; 16(8): 596-604. google scholar
11. Pal S, Konkimalla VB. Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death. Mini Rev Med Chem 2016; 16(12): 980-95. google scholar
12. Son TG, Camandola S, Mattson MP. Hormetic dietary phytochemi-cals. Neuromolecular Med 2008; 10(4): 236-46. google scholar
13. Jodynis-Liebert J, Kujawska M. Biphasic Dose-Response Induced by Phytochemicals: Experimental Evidence. Journal of Clinical Medicine 2020; 9(3): 718. google scholar
14. Narter F, Diren A, Kafkasli A, Eronat AP, Seyhan MF, Yilmaz-Aydogan H, et al. Anatolian Propolis Prevents Oxalate Kidney Stones: Dra-matic Reduction of Crystal Deposition in Ethylene-Glycol-Induced Rat Model. Rec Nat Prod 2018; 12(5): 445-59. google scholar
15. Huang KT, Chen YH, Walker AM. Inaccuracies in MTS assays: major distorting effects of medium, serum albumin, and fatty acids. Bio-techniques 2004 Sep; 37(3): 406, 408, 410-2. google scholar
16. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009; 6(5): 359-62. google scholar
17. Akgun E, Tuzuner MB, Sahin B, Kilercik M, Kulah C, Cakiroglu HN, et al. Proteins associated with neutrophil degranulation are upreg-ulated in nasopharyngeal swabs from SARS-CoV-2 patients. PLoS One 2020; 15(10): e0240012 google scholar
18. Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S, AmiGO Hub; Web Presence Working Group. AmiGO: online access to on-tology and annotation data. Bioinformatics 2009; 25(2): 288-9. google scholar
19. Batra P, Sharma AK. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech 2013; 3(6): 439-59. google scholar
20. Coller HA. Is cancer a metabolic disease? Am J Pathol 2014; 184(1): 4-17. google scholar
21. Pavlova NN, Thompson CB. The emerging hallmarks of cancer me-tabolism. Cell Metab 2016; 23(1): 27-47. google scholar
22. Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 2016; 41(3): 211-8. google scholar
23. Richardson AD, Yang C, Osterman A, Smith JW. Central carbon me-tabolism in the progression of mammary carcinoma. Breast Cancer Res Treat 2008; 110(2): 297-307. google scholar
24. Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, et al. Flavonoids against the Warburg phenotype-concepts of pre-dictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J 2020; 11(3): 377-98. google scholar
25. Zang HY,Gong LG, Li SY, HaoJG. Inhibition ofa-enolaseaffects the biological activity of breast cancer cells by attenuating PI3K/Akt signaling pathway. Eur Rev Med Pharmacol Sci 2020; 24(1): 249-57. google scholar
26. Locasale JW. Serine, glycine and one-carbon units: cancer metabo-lism in full circle. Nat Rev Cancer 2013; 13: 572-83. google scholar
27. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476(7360): 346-50. google scholar
28. Liu C, Wang L, Liu X, Tan Y, Tao L, Xiao Y, et al. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by in-hibiting 0-catenin degradation.Theranostics 2021; 11(6): 2966-86. google scholar
29. Maniatis T, Reed R. An extensive network of coupling among gene expression machines. Nature 2002; 416: 499-506. google scholar
30. Millevoi S, Vagner S. Molecular mechanisms of eukaryotic pre-mR-NA 3’ end processing regulation. Nucleic Acids Res 2009; 38: 275774. google scholar
31. Orphanides G, Reinberg D. A unified theory of gene expression. Cell 2002; 108: 439-51. google scholar
32. Scotti MM, Swanson MS. RNA mis-splicing in disease. Nat Rev Gen-et 2016; 17(1): 19-32. google scholar
33. Kurata M, Fujiwara N, Fujita KI, Yamanaka Y, Seno S, Kobayashi H, et al. Food-Derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites. iScience 2019; 22: 336-52. google scholar
34. Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet 2016; 135(8): 851-67. google scholar
35. Silipo M, Gautrey H, Tyson-Capper A. Deregulation of splicing fac-tors and breast cancer development. J Mol Cell Biol 2015; 7(5): 388401. google scholar
36. Calderwood SK, Gong J. Heat Shock Proteins Promote Cancer: It’s a Protection Racket. Trends Biochem Sci 2016; 41(4): 311-23. google scholar
37. Hosokawa N, Hirayoshi K, Nakai A, Hosokawa Y, Marui N, Yoshida M, et al. Flavonoids inhibit the expression of heat shock proteins. Cell Struct Funct 1990; 15(6): 393-401. google scholar
38. Wadhwa R, Yaguchi T, Hasan MK, Mitsui Y, Reddel RR, Kaul SC. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cy-toplasmic sequestration domain of the p53 protein. Exp Cell Res 2002; 274(2): 246-53. google scholar
39. Wadhwa R, Takano S, Kaur K, Deocaris CC, Pereira-Smith OM, Red-del RR, et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer 2006; 118(12): 2973-80. google scholar
40. Na Y, Kaul SC, Ryu J, Lee JS, Ahn HM, Kaul Z et al. Stress chaperone mortalin contributes to epithelial-mesenchymal transition and cancer metastasis. Cancer Res 2016; 76(9): 2754-65. google scholar
41. Zhang R, Meng Z, Wu X, Zhang M, Zhang S, Jin T. Mortalin pro-motes breast cancer malignancy. Exp Mol Pathol 2021;118:104593. google scholar
42. Huang TC, Chang HY, Hsu CH, Kuo WH, Chang KJ, Juan HF. Target-ing therapy for breast carcinoma by ATP synthase inhibitor au-rovertin B. J Proteome Res 2008; 7: 1433-44. google scholar
43. Pan J, Sun LC, Tao YF, Zhou Z, Du XL, Peng L, et al. ATP synthase ecto-alpha subunit: a novel therapeutic target for breast cancer. J Transl Med 2011; 9: 211. google scholar
44. Isidoro A, Casado E, Redondo A, Acebo P, Espinosa E, Alonso AM, et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 2005; 26: 2095-104. google scholar
45. Willers IM, Cuezva JM. Post-transcriptional regulation of the mi-tochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer. Biochim Biophys Acta 2011; 1807: 543-51. google scholar
46. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamana G, Kim H, et al. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 2002; 62: 6674-81. google scholar
47. Zheng SQ, Li YX, Zhang Y, Li X, Tang H. MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res 2011; 89: 219-26. google scholar
48. Bilanges B, Stokoe D. Mechanism of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973-90. google scholar
49. Hassan MK, Kumar D, Naik M, Dixit M. The expression profile and prognostic significance of eukaryotic translation elongation fac-tors in different cancers. PLoS One 2018; 13(1): e0191377. google scholar
50. Meric-Bernstam F, Chen H, Akcakanat A, Do KA, Lluch A, Hennessy BT, Hortobagyi GN, Mills GB, et al. Aberrations in translational regulation are associated with poor prognosis in hormone recep-tor-positive breast cancer. Breast Cancer Res 2012; 14: R138. google scholar
51. Yao N, Chen CY, Wu CY, Motonishi K, Kung HJ, Lam KS. Novel flavo-noids with antiproliferative activities against breast cancer cells. J Med Chem 2011; 54(13): 4339-49. google scholar
52. Xu L, Wang L, Jiang C, Zhu Q, Chen R, Wang J, et al. Biological effect of ribosomal protein L32 on human breast cancer cell behavior. Mol Med Rep 2020; 22(3): 2478-86. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format

EXPORT

APA

Tüzüner, M.B., & Ceviz, A.B. (2021). Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture. European Journal of Biology, 80(2), 145-153. https://doi.org/10.26650/EurJBiol.2021.1017807

AMA

Tüzüner M B, Ceviz A B. Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture. European Journal of Biology. 2021;80(2):145-153. https://doi.org/10.26650/EurJBiol.2021.1017807

ABNT

Tüzüner, M.B.; Ceviz, A.B. Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture. European Journal of Biology, [Publisher Location], v. 80, n. 2, p. 145-153, 2021.

Chicago: Author-Date Style

Tüzüner, Mete Bora, and Ayşe Begüm Ceviz. 2021. “Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture.” European Journal of Biology 80, no. 2: 145-153. https://doi.org/10.26650/EurJBiol.2021.1017807

Chicago: Humanities Style

Tüzüner, Mete Bora, and Ayşe Begüm Ceviz. “Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture.” European Journal of Biology 80, no. 2 (Jun. 2025): 145-153. https://doi.org/10.26650/EurJBiol.2021.1017807

Harvard: Australian Style

Tüzüner, MB & Ceviz, AB 2021, 'Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture', European Journal of Biology, vol. 80, no. 2, pp. 145-153, viewed 6 Jun. 2025, https://doi.org/10.26650/EurJBiol.2021.1017807

Harvard: Author-Date Style

Tüzüner, M.B. and Ceviz, A.B. (2021) ‘Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture’, European Journal of Biology, 80(2), pp. 145-153. https://doi.org/10.26650/EurJBiol.2021.1017807 (6 Jun. 2025).

MLA

Tüzüner, Mete Bora, and Ayşe Begüm Ceviz. “Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture.” European Journal of Biology, vol. 80, no. 2, 2021, pp. 145-153. [Database Container], https://doi.org/10.26650/EurJBiol.2021.1017807

Vancouver

Tüzüner MB, Ceviz AB. Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture. European Journal of Biology [Internet]. 6 Jun. 2025 [cited 6 Jun. 2025];80(2):145-153. Available from: https://doi.org/10.26650/EurJBiol.2021.1017807 doi: 10.26650/EurJBiol.2021.1017807

ISNAD

Tüzüner, MeteBora - Ceviz, AyşeBegüm. “Proteomic Analysis Revealed Underlying Biological Pathways Associated with Hormetic Response of Hormone Positive Breast Cancer Cell Line Exposed to Low-Dose Flavonoid Mixture”. European Journal of Biology 80/2 (Jun. 2025): 145-153. https://doi.org/10.26650/EurJBiol.2021.1017807

Volume 80, Issue 22021, P. 145-153

TIMELINE

Submitted	02.11.2021
Accepted	21.11.2021
Published Online	09.12.2021

LICENCE

Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.

European Journal of Biology